Sevaro Health

The firm's business model is centered on partnering with hospitals and healthcare systems to augment their neurological care capabilities. Sevaro provides these institutions with a subscription-based platform and access to a team of neurology specialists, operating on a Software-as-a-Service (SaaS) model. This approach enables client hospitals to manage acute neurological events more effectively, improve patient outcomes, and ensure a continuum of care from the emergency room to outpatient follow-up. The company has secured significant financial backing to support its growth, with funding rounds including investments from Catalyst Investors and APA Venture Partners.

At the core of Sevaro's offering is the Synapse AI virtual neurology platform, which is designed to integrate seamlessly into a hospital's existing workflow. A key feature of this platform is the proprietary OneCall™ technology, which dramatically reduces the time it takes for hospital staff to connect with an on-call vascular neurologist to under 45 seconds. Beyond emergent stroke care, the company's services extend to a comprehensive suite of virtual neurology solutions. These include 24/7 telestroke and acute neurology coverage, remote EEG reading, virtual neuro-intensive care, neurohospitalist rounding, and ambulatory clinics for follow-up care. This specialized, all-encompassing focus on neurology allows the company to provide a depth of expertise. A notable achievement for the company was earning The Joint Commission's Gold Seal of Approval® for Ambulatory Health Care, underscoring its commitment to high standards of patient care and safety.